Last reviewed · How we verify

NCT07373912: CGH

Impact of Adding Instrument-assisted Soft Tissue Mobilization to Mulligan Therapy in Patients With Cervicogenic Headache

Not yet recruiting NA Last updated 28 January 2026
What this trial tests

NA trial testing instrumeted assissted soft tissue mobilization and mulligan therapy in Cervicogenic Headache in 60 participants. Not yet recruiting.

Timeline
1 February 2026
Primary endpoint
1 July 2026
1 July 2026

Quick facts

Lead sponsorCairo University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date1 February 2026
Primary completion1 July 2026
Estimated completion1 July 2026

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 70, any sex, with Cervicogenic Headache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

this study will be conducted to investigate the impact of adding Instrument assisted soft tissue mobilization technique to mulligan therapy in patients with cervicogenic headache

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cervicogenic Headache

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07373912.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing